Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 59803

In vitro sensitivity of B-CLL cells to fludarabine, anti-CD20 (rituximab) and anti-CD52 (campath-1H)


Grdiša, Mira; Ajchenbaum-Cymbalista, Florence; Tang, Rou Ping; Marie, Jean Piere; Delmer, Alain
In vitro sensitivity of B-CLL cells to fludarabine, anti-CD20 (rituximab) and anti-CD52 (campath-1H) // Blood 96(11) / Schechter, G.P. (ur.).
San Francisco (CA): Amgen Inc., 2000. str. 692-692 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 59803 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
In vitro sensitivity of B-CLL cells to fludarabine, anti-CD20 (rituximab) and anti-CD52 (campath-1H)

Autori
Grdiša, Mira ; Ajchenbaum-Cymbalista, Florence ; Tang, Rou Ping ; Marie, Jean Piere ; Delmer, Alain

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Blood 96(11) / Schechter, G.P. - San Francisco (CA) : Amgen Inc., 2000, 692-692

Skup
42sd Annual Meeting American Society of Hematology

Mjesto i datum
San Francisco (CA), Sjedinjene Američke Države, 01.12.2000. - 05.12.2000

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
rituxan; leukemia; chronic B cell

Sažetak
Nm

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
00981104

Ustanove:
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Mirica Grdiša (autor)


Citiraj ovu publikaciju:

Grdiša, Mira; Ajchenbaum-Cymbalista, Florence; Tang, Rou Ping; Marie, Jean Piere; Delmer, Alain
In vitro sensitivity of B-CLL cells to fludarabine, anti-CD20 (rituximab) and anti-CD52 (campath-1H) // Blood 96(11) / Schechter, G.P. (ur.).
San Francisco (CA): Amgen Inc., 2000. str. 692-692 (poster, međunarodna recenzija, sažetak, znanstveni)
Grdiša, M., Ajchenbaum-Cymbalista, F., Tang, R., Marie, J. & Delmer, A. (2000) In vitro sensitivity of B-CLL cells to fludarabine, anti-CD20 (rituximab) and anti-CD52 (campath-1H). U: Schechter, G. (ur.)Blood 96(11).
@article{article, author = {Grdi\v{s}a, Mira and Ajchenbaum-Cymbalista, Florence and Tang, Rou Ping and Marie, Jean Piere and Delmer, Alain}, editor = {Schechter, G.}, year = {2000}, pages = {692-692}, keywords = {rituxan, leukemia, chronic B cell}, title = {In vitro sensitivity of B-CLL cells to fludarabine, anti-CD20 (rituximab) and anti-CD52 (campath-1H)}, keyword = {rituxan, leukemia, chronic B cell}, publisher = {Amgen Inc.}, publisherplace = {San Francisco (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave} }
@article{article, author = {Grdi\v{s}a, Mira and Ajchenbaum-Cymbalista, Florence and Tang, Rou Ping and Marie, Jean Piere and Delmer, Alain}, editor = {Schechter, G.}, year = {2000}, pages = {692-692}, keywords = {rituxan, leukemia, chronic B cell}, title = {In vitro sensitivity of B-CLL cells to fludarabine, anti-CD20 (rituximab) and anti-CD52 (campath-1H)}, keyword = {rituxan, leukemia, chronic B cell}, publisher = {Amgen Inc.}, publisherplace = {San Francisco (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave} }




Contrast
Increase Font
Decrease Font
Dyslexic Font